Molecular and Cell Biology of Human Gene Therapeutics (Molecular and Cell Biology of Human Diseases Series)

0 avg rating
( 0 ratings by Goodreads )
 
9780412625503: Molecular and Cell Biology of Human Gene Therapeutics (Molecular and Cell Biology of Human Diseases Series)

advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu­ lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari­ ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro­ vides good palliation for the patient in a manner that differs essentially from chemotherapy.

"synopsis" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Published by Chapman and Hall, United Kingdom (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)
Rating
[?]

Book Description Chapman and Hall, United Kingdom, 1995. Hardback. Book Condition: New. 1995 ed.. Language: English . This book usually ship within 10-15 business days and we will endeavor to dispatch orders quicker than this where possible. Brand New Book. advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu- lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari- ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro- vides good palliation for the patient in a manner that differs essentially from chemotherapy. Bookseller Inventory # LIE9780412625503

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 203.21
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

2.

Dickson, George
Published by Springer (2016)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Springer, 2016. Paperback. Book Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Bookseller Inventory # ria9780412625503_lsuk

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 203.22
Convert Currency

Add to Basket

Shipping: £ 3.88
From United Kingdom to U.S.A.
Destination, Rates & Speeds

3.

Published by Springer (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Springer, 1995. Hardcover. Book Condition: New. book. Bookseller Inventory # M0412625504

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 207.44
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

4.

G. DICKSON
Published by Springer (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Springer, 1995. Hardback. Book Condition: NEW. 9780412625503 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Bookseller Inventory # HTANDREE0277766

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 216.70
Convert Currency

Add to Basket

Shipping: £ 8
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Published by Chapman and Hall, United Kingdom (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 10
Print on Demand
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Chapman and Hall, United Kingdom, 1995. Hardback. Book Condition: New. 1995 ed.. Language: English . Brand New Book ***** Print on Demand *****.advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu- lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari- ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro- vides good palliation for the patient in a manner that differs essentially from chemotherapy. Bookseller Inventory # APC9780412625503

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 244.74
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Published by Springer
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Quantity Available: 1
Seller:
Majestic Books
(London, ,, United Kingdom)
Rating
[?]

Book Description Springer. Book Condition: New. pp. 424. Bookseller Inventory # 8360578

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 241.61
Convert Currency

Add to Basket

Shipping: £ 5.50
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Published by Chapman and Hall, United Kingdom (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 10
Print on Demand
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Chapman and Hall, United Kingdom, 1995. Hardback. Book Condition: New. 1995 ed.. Language: English . Brand New Book ***** Print on Demand *****. advanced metastatic disease of solid tumors, dictates that each tumor mass, indeed each individual metastasis, will have a unique antigen and cytokine environment and hence unique response to immune modu- lation. A differential response to immunotherapy is thus inevitable. 4. Many of the human trials described are not randomized and report survival or response against historical controls. Most tumors described are immunogenic human tumors: renal cell cancer and melanoma are most common. In order to avoid the well-described inter-patient vari- ation and rare incidence of spontaneous response among patient samples as well as selection bias and changes in practice over time, randomized trials are required. 5. Immunological treatment is unlike conventional chemotherapy in its endpoint. Most chemotherapeutic regimes require a complete response or a good partial response for cure or good palliation. There are now many cases where immunotherapy has provided long-term palliation without massive tumor reduction. Immunity may be stimulated to a degree which holds tumorigenicity in check and most importantly, pro- vides good palliation for the patient in a manner that differs essentially from chemotherapy. Bookseller Inventory # APC9780412625503

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 253.30
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

8.

Published by Springer (1995)
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: 15
Print on Demand
Seller:
Rating
[?]

Book Description Springer, 1995. Book Condition: New. This item is printed on demand for shipment within 3 working days. Bookseller Inventory # LP9780412625503

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 264.24
Convert Currency

Add to Basket

Shipping: £ 2.64
From Germany to U.S.A.
Destination, Rates & Speeds

9.

Published by Springer
ISBN 10: 0412625504 ISBN 13: 9780412625503
New Hardcover Quantity Available: > 20
Seller:
BuySomeBooks
(Las Vegas, NV, U.S.A.)
Rating
[?]

Book Description Springer. Hardcover. Book Condition: New. 403 pages. Dimensions: 9.2in. x 6.1in. x 1.0in.Written to inform not only basic research scientists and students, but also practising physicians, this volume reviews the evolution of gene transfer as a therapeutic strategy. The latest developments in viral and non-viral vectors for gene therapy are explained. The book then moves on to describe gene therapy applications in a comprehensive range of disease situations including cancer, AIDS, arthritis, cardiovascular and neuromuscular disorders, and cystic fibrosis as well as genetic vaccination. This item ships from multiple locations. Your book may arrive from Roseburg,OR, La Vergne,TN. Hardcover. Bookseller Inventory # 9780412625503

More Information About This Seller | Ask Bookseller a Question

Buy New
£ 362.27
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds